36111120|t|Opioid-free total intravenous anesthesia for thyroid and parathyroid surgery: Protocol for a randomized, double-blind, controlled trial.
36111120|a|Background: Opioid-free anesthesia (OFA) may improve postoperative outcomes by reducing opioid-related adverse effects. This study aims to evaluate the effects of OFA on postoperative nausea and vomiting (PONV), postoperative pain, and 30-day outcomes after thyroid and parathyroid surgery. Methods: This two-center, randomized, double-blind, controlled trial will include 400 adult patients scheduled for thyroid and parathyroid surgery. Patients will be randomly assigned, 1:1 and stratified by sex and site, to an OFA group (esketamine, lidocaine, and dexmedetomidine) or a control group (opioid-based anesthesia with sufentanil). All patients will receive propofol-based total intravenous anesthesia and PONV prophylaxis with dexamethasone and ondansetron. The primary outcome is the incidence of PONV (defined as experiencing any event of nausea, retching, or vomiting) during the first 48 h postoperatively. The secondary outcomes include the severity of PONV, antiemetic rescue therapy, pain scores at rest and while coughing, need for rescue analgesia, perioperative adverse effects related to anesthetics or analgesics (hypotension, bradycardia, hypertension, tachycardia, desaturation, dizziness, headache, hallucination, and nightmare), time to extubation, length of post-anesthesia care unit stay, length of postoperative hospital stay, patient satisfaction, and a composite of 30-day major adverse events (myocardial infarction, cardiac arrest, cerebrovascular accident, coma, acute renal failure, pulmonary embolism, sepsis, septic shock, deep neck space infection, reintubation, reoperation, blood transfusion, failure to wean off ventilator, and death). Analyses will be performed in the modified intention-to-treat population. Discussion: We hypothesize that our OFA regimen reduces PONV after thyroid and parathyroid surgery. We will also investigate whether OFA leads to improvements in postoperative pain and major adverse events. Our results will offer evidence for optimizing anesthesia regimens in patients who undergo thyroid and parathyroid surgical procedures. Clinical trial registration: http://www.chictr.org.cn, identifier: ChiCTR2200059656.
36111120	53	68	and parathyroid	Disease	MESH:D010279
36111120	307	340	postoperative nausea and vomiting	Disease	MESH:D020250
36111120	342	346	PONV	Disease	MESH:D020250
36111120	349	367	postoperative pain	Disease	MESH:D010149
36111120	403	418	and parathyroid	Disease	MESH:D010279
36111120	520	528	patients	Species	9606
36111120	551	566	and parathyroid	Disease	MESH:D010279
36111120	576	584	Patients	Species	9606
36111120	665	675	esketamine	Chemical	MESH:C000629870
36111120	677	686	lidocaine	Chemical	MESH:D008012
36111120	692	707	dexmedetomidine	Chemical	MESH:D020927
36111120	758	768	sufentanil	Chemical	MESH:D017409
36111120	775	783	patients	Species	9606
36111120	797	805	propofol	Chemical	MESH:D015742
36111120	845	849	PONV	Disease	MESH:D020250
36111120	867	880	dexamethasone	Chemical	MESH:D003907
36111120	885	896	ondansetron	Chemical	MESH:D017294
36111120	938	942	PONV	Disease	MESH:D020250
36111120	981	987	nausea	Disease	MESH:D009325
36111120	1002	1010	vomiting	Disease	MESH:D014839
36111120	1098	1102	PONV	Disease	MESH:D020250
36111120	1131	1135	pain	Disease	MESH:D010146
36111120	1266	1277	hypotension	Disease	MESH:D007022
36111120	1279	1290	bradycardia	Disease	MESH:D001919
36111120	1292	1304	hypertension	Disease	MESH:D006973
36111120	1306	1317	tachycardia	Disease	MESH:D013610
36111120	1319	1331	desaturation	Disease	
36111120	1333	1342	dizziness	Disease	MESH:D004244
36111120	1344	1352	headache	Disease	MESH:D006261
36111120	1354	1367	hallucination	Disease	MESH:D006212
36111120	1486	1493	patient	Species	9606
36111120	1556	1577	myocardial infarction	Disease	MESH:D009203
36111120	1579	1593	cardiac arrest	Disease	MESH:D006323
36111120	1595	1619	cerebrovascular accident	Disease	MESH:D020521
36111120	1621	1625	coma	Disease	MESH:D003128
36111120	1627	1646	acute renal failure	Disease	MESH:D058186
36111120	1648	1666	pulmonary embolism	Disease	MESH:D011655
36111120	1668	1674	sepsis	Disease	MESH:D018805
36111120	1676	1688	septic shock	Disease	MESH:D012772
36111120	1690	1715	deep neck space infection	Disease	MESH:D006258
36111120	1799	1804	death	Disease	MESH:D003643
36111120	1937	1941	PONV	Disease	MESH:D020250
36111120	1956	1971	and parathyroid	Disease	MESH:D010279
36111120	2043	2061	postoperative pain	Disease	MESH:D010149
36111120	2158	2166	patients	Species	9606
36111120	2187	2202	and parathyroid	Disease	MESH:D010279
36111120	Negative_Correlation	MESH:D017294	MESH:D020250
36111120	Negative_Correlation	MESH:D003907	MESH:D020250

